gvtcx

Serialisation Automation

NHS South West - Acutes Published 20 Aug 2020 Contracts Finder

key details

Value£240,000
Statusactive
Category (CPV) 42900000
Deadline22 Sept 2020
Contract start23 Sept 2020
Contract end24 Sept 2023
Procedureopen
SME suitableYes
OCIDocds-b5fd17-d64696b9-1ffd-4c34-ab53-ccd18efee5a9

description

Torbay Pharmaceuticals have been manufacturing pharmaceuticals for over 35 years and is wholly owned by Torbay and South Devon NHS Foundation Trust. They are currently the largest NHS pharmaceutical manufacturing unit in the UK and manufactures unlicensed and licensed essential pharmaceuticals and CE Marked Medical Devices across a wide range of therapeutic areas. Annual Turnover is circa £20m pa and all profits are returned to the NHS Trust. On the 9th February 2019 new EU legislation came in to affect that all Licenced Products should comply with Falsified Medicines Directive. Torbay Pharmaceuticals purchased the Antares Solution to enable the application of a Unique Identifier. 2 Machines were purchased to enable TP to apply the required 2-D Barcode and Decommission where necessary. This was Phase 1 of the project. In order to ensure we are able to meet the demands of our current and future customers, automation is essential. The need to purchase an Automated Solution that will apply both the 2-D Barcode and the tamper evident label is required for each of our production lines, Ampoules and Vials.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
8 Sept 2020 Tender amendment (tenderAmendment) · 662bb305-d556-4c29-b12c-a4b31c6c7f2e-380028

more from NHS South West - Acutes

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.